Global Sodium Valproate Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sodium Valproate Market Research Report 2024
Valproate (VPA), and its valproic acid, sodium valproate, and valproate semisodium forms, are medications primarily used to treat epilepsy and bipolar disorder and to prevent migraine headaches. It is useful for the prevention of seizures in those with absence seizures, partial seizures, and generalized seizures.
According to Mr Accuracy reports new survey, global Sodium Valproate market is projected to reach US$ 252.5 million in 2029, increasing from US$ 167 million in 2022, with the CAGR of 5.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sodium Valproate market research.
Key manufacturers engaged in the Sodium Valproate industry include Sanofi, AbbVie, Athenex, Fresenius Kabi, Hikma Farmaceutica, Desitin Pharmaceuticals, Wockhardt and Zentiva, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sodium Valproate were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sodium Valproate market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Valproate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Sanofi
AbbVie
Athenex
Fresenius Kabi
Hikma Farmaceutica
Desitin Pharmaceuticals
Wockhardt
Zentiva
Segment by Type
Injection
Tablet
Liquid
Epilepsy
Migraines
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sodium Valproate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Sodium Valproate market is projected to reach US$ 252.5 million in 2029, increasing from US$ 167 million in 2022, with the CAGR of 5.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sodium Valproate market research.
Key manufacturers engaged in the Sodium Valproate industry include Sanofi, AbbVie, Athenex, Fresenius Kabi, Hikma Farmaceutica, Desitin Pharmaceuticals, Wockhardt and Zentiva, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sodium Valproate were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sodium Valproate market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Valproate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi
AbbVie
Athenex
Fresenius Kabi
Hikma Farmaceutica
Desitin Pharmaceuticals
Wockhardt
Zentiva
Segment by Type
Injection
Tablet
Liquid
Segment by Application
Epilepsy
Migraines
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sodium Valproate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source